A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
Active, not recruiting · NCT06709014 · Registry updated 2026-05-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Phase 3 | 2026-05-18 | NCT06709014 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Annovis Bio Inc. | 3 |
| Prevail Infoworks | 3 |
| ProPharma Group | 3 |
77 results · Page 1 of 4
Research sites
Swipe the table sideways for more columns.